JPMORGAN CHASE & CO - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 49 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q1 2018$203,000
+6666.7%
101,118
+4715.1%
0.00%
Q4 2017$3,000
-88.5%
2,100
-89.9%
0.00%
Q3 2017$26,000
+18.2%
20,860
+25.2%
0.00%
Q2 2017$22,000
-26.7%
16,660
+3.2%
0.00%
Q1 2017$30,000
-76.7%
16,150
-35.0%
0.00%
Q4 2016$129,00024,8630.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q3 2017
NameSharesValueWeighting ↓
22NW, LP 155,000$206,0000.12%
Birchview Capital, LP 128,000$170,0000.09%
CARL DOMINO INC 43,273$58,0000.07%
NORTHERN CAPITAL MANAGEMENT LLC 106,050$141,0000.05%
ELEMENT CAPITAL MANAGEMENT LLC 124,423$165,0000.03%
Baker Brothers Advisors 1,618,089$2,152,0000.02%
SIMON QUICK ADVISORS, LLC 24,390$32,0000.02%
ARTHUR M. COHEN & ASSOCIATES, LLC 31,390$42,0000.02%
WHITE PINE CAPITAL LLC 20,000$27,0000.01%
LMR Partners LLP 112,265$149,0000.01%
View complete list of AEVI GENOMIC MEDICINE INC shareholders